Warning letters, 483s, Recalls, Import Alerts, Audit observations
USFDA 483 to Intas cites lapses in investigation and review of failures and discrepancies in
USFDA483 to Intas cites manipulated visual inspection reports; failure to characterise particles observed in injection
Accord USA has initiated recall of multiple lots of Atropine Sulfate, USP 8 mg per
FDA published the USFDA483 issued to Intas site (FEI 3003157498) in Ahmedabad, India after inspection
Warning letter / Centrient India / MARCS-CMS 640196/ 320-23-06/ DECEMBER 07, 2022/ Observation 3 The
